K. Roos Ljungberg

Elevated free secretory component in early rheumatoid arthritis and prior to arthritis development in patients at increased risk

J. Wetterö, C. Sjöwall, T. Skogh, 2019, Rheumatology.

Extramucosal Formation and Prognostic Value of Secretory Antibodies in Rheumatoid Arthritis

J. Wetterö, S. Paul, A. Kastbom, 2021, Arthritis & rheumatology.

Secretory antibodies to citrullinated peptides in plasma and saliva from rheumatoid arthritis patients and their unaffected first‐degree relatives

C. Sjöwall, A. Kastbom, S. Rantapää Dahlqvist, 2019, Clinical and experimental immunology.

Secretory anti-citrullinated protein antibodies in serum associate with lung involvement in early rheumatoid arthritis

R. Karimi, C. Sköld, A. Eklund, 2019, Rheumatology.

Changes in anti‐citrullinated protein antibody isotype levels in relation to disease activity and response to treatment in early rheumatoid arthritis

J. Wetterö, T. Skogh, A. Kastbom, 2018, Clinical and experimental immunology.

Circulating anti‐citrullinated protein antibodies containing secretory component are prognostic for arthritis onset in at‐risk patients

J. Wetterö, A. Kastbom, A. Svärd, 2021, Clinical and experimental immunology.

Presence of salivary IgA anti-citrullinated protein antibodies associate with higher disease activity in patients with rheumatoid arthritis

J. Wetterö, A. Kastbom, A. Svärd, 2020, Arthritis Research & Therapy.